Halozyme Therapeutics shares owned by Connecticut Wealth Management
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Connecticut Wealth Management
from 13F filings
Historical chart of Connecticut Wealth Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Connecticut Wealth Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Connecticut Wealth Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $363k | 4.9k | 73.34 |
| 2025-06-30 | $283k | 5.4k | 52.02 |
| 2025-03-31 | $357k | 5.6k | 63.81 |
| 2024-12-31 | $267k | 5.6k | 47.81 |
| 2024-09-30 | $317k | 5.5k | 57.24 |
| 2024-06-30 | $318k | 6.1k | 52.36 |
| 2024-03-31 | $239k | 5.9k | 40.68 |
| 2023-12-31 | $215k | 5.8k | 36.96 |
| 2023-09-30 | $222k | 5.8k | 38.20 |
| 2023-06-30 | $210k | 5.8k | 36.07 |
More positions owned by Connecticut Wealth Management
View all positions for Connecticut Wealth Management